D-β-Hydroxybutyrate Is Protective in Mouse Models of Huntington's Disease
Open Access
- 12 September 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 6 (9), e24620
- https://doi.org/10.1371/journal.pone.0024620
Abstract
Abnormalities in mitochondrial function and epigenetic regulation are thought to be instrumental in Huntington's disease (HD), a fatal genetic disorder caused by an expanded polyglutamine track in the protein huntingtin. Given the lack of effective therapies for HD, we sought to assess the neuroprotective properties of the mitochondrial energizing ketone body, D-β-hydroxybutyrate (DβHB), in the 3-nitropropionic acid (3-NP) toxic and the R6/2 genetic model of HD. In mice treated with 3-NP, a complex II inhibitor, infusion of DβHB attenuates motor deficits, striatal lesions, and microgliosis in this model of toxin induced-striatal neurodegeneration. In transgenic R6/2 mice, infusion of DβHB extends life span, attenuates motor deficits, and prevents striatal histone deacetylation. In PC12 cells with inducible expression of mutant huntingtin protein, we further demonstrate that DβHB prevents histone deacetylation via a mechanism independent of its mitochondrial effects and independent of histone deacetylase inhibition. These pre-clinical findings suggest that by simultaneously targeting the mitochondrial and the epigenetic abnormalities associated with mutant huntingtin, DβHB may be a valuable therapeutic agent for HD.Keywords
This publication has 60 references indexed in Scilit:
- Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activityNature Medicine, 2011
- Nicotinamide improves motor deficits and upregulates PGC-1α and BDNF gene expression in a mouse model of Huntington's diseaseNeurobiology of Disease, 2011
- Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damageHuman Molecular Genetics, 2011
- Mitochondrial loss, dysfunction and altered dynamics in Huntington's diseaseHuman Molecular Genetics, 2010
- The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington's disease transgenic miceProceedings of the National Academy of Sciences of the United States of America, 2008
- Effects of β-hydroxybutyrate on cognition in memory-impaired adultsNeurobiology of Aging, 2004
- Huntington's Disease of the Endocrine Pancreas: Insulin Deficiency and Diabetes Mellitus due to Impaired Insulin Gene ExpressionNeurobiology of Disease, 2002
- The Role of Protein Composition in Specifying Nuclear Inclusion Formation in Polyglutamine DiseaseOnline Journal of Public Health Informatics, 2001
- Metabolism of Ketone Bodies by the BrainAnnual Review of Medicine, 1973
- INCREASED FREQUENCY OF DIABETES MELLITUS IN PATIENTS WITH HUNTINGTON'S CHOREAThe Lancet, 1972